Download PDF
Exp Clin Endocrinol Diabetes 2010; 118(6): 346-352
DOI: 10.1055/s-0029-1243604
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Genetic Variation in the G-50T Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 Gene and the Risk of Younger Onset Type 2 Diabetes among Chinese Population: Potential Interaction with Body Mass Index and Family History

C.-P. Wang1 , 4 , W.-C. Hung1 , T.-H. Yu1 , C.-A. Chiu1 , L.-F. Lu2 , F.-M. Chung1 , C.-H. Hung4 , S.-J. Shin5 , H.-J. Chen3 , Y.-J. Lee6
  • 1Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
  • 2Division of Cardiac Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
  • 3Division of Neurology, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
  • 4Department of Medical Nutrition, Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan
  • 5Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  • 6Lee's Endocrinologic Clinic, Pingtung, Taiwan
Further Information

Publication History

received 02.10.2009 first decision 02.10.2009

accepted 25.11.2009

Publication Date:
05 February 2010 (online)

Also available at
    Permissions and Reprints

Abstract

Background: Cytochrome P450 (CYP) 2J2 is a regulatory enzyme in the biosynthesis of biologically active cis-epoxyeicosatrienoic acids (EETs). EETs have been suggested to modulate PPAR-γ and PPAR-α transcription activity and play a role in stimulus-secretion coupling in pancreatic beta cells. Genetic abnormalities in the expression of CYP2J enzymes may play a role in the pathogenesis of type 2 diabetes mellitus (T2DM). Our objective was to investigate CYP2J2 G-50T polymorphism (rs890293) in association with insulin resistance markers and T2DM in a Chinese population.

Methods: A total of 1 747 Chinese T2DM patients and 994 non-diabetic subjects were studied. The CYP2J2 G-50T polymorphism was determined by a restriction fragment-length polymorphism polymerase chain reaction.

Results: Neither the CYP2J2 genotype distribution nor allele frequency differed between the control subjects and the T2DM patients. However, among diabetics, subjects with a younger age at diagnosis (AAD; <40 years) had significantly higher T variant frequency than those with an AAD≥40 years. When diabetic patients were stratified by their AAD in 10-year intervals, the trend was significantly linear among age grades. A significant interaction between the CYP2J2 T variant and younger onset diabetic subjects with positive family diabetes history, and BMI≥27 kg/m2 were observed to have the highest risk of diabetes and younger onset diabetics with the T variant had higher homeostasis model assessment estimate of insulin resistance (HOMA-IR) and HOMA-β values than their GG genotype counterparts. Plasma concentrations of stable EET metabolites were significantly lower in individuals with the G-50T SNP in younger onset diabetics.

Conclusion: These data suggest that age of onset, family history, and obesity may modify the association between the CYP2J2 G-50T polymorphism and T2DM risk. CYP2J2 G-50T polymorphism may contribute to the pathogenesis of T2DM, partially by effects on insulin resistance, in patients with younger onset T2DM.

Key words

younger onset type 2 diabetes - CYP2J2 G-50T polymorphism - obesity - family history - insulin resistance

References

  • 1 American Diabetes Association. . Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2007;  30 S42-S47
    Google Scholar
  • 2 Anuradha S, Radha V, Deepa R. et al . A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians.  Diabetes Care. 2005;  28 2430-2435
    Google Scholar
  • 3 Bacci S, Ludovico O, Prudente S. et al . The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction.  Diabetes. 2005;  54 3021-3025
    Google Scholar
  • 4 Chen MP, Chung FM, Chang DM. et al . Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.  J Clin Endocrinol Metab. 2006;  91 295-299
    Google Scholar
  • 5 Chung FM, Tsai JC, Chang DM. et al . Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis.  Diabetes Care. 2005;  28 1710-1717
    Google Scholar
  • 6 Cornfield J. A method of estimating comparative rates from clinical data. Applications to cancer of the lung, breast and cervix.  J Natl Cancer Inst. 1951;  11 1269-1275
    Google Scholar
  • 7 Cowart LA, Wei S, Hsu MH. et al . The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands.  J Biol Chem. 2002;  277 35105-35112
    Google Scholar
  • 8 Falck JR, Manna S, Moltz J. et al . Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets.  Biochem Biophys Res Commun. 1983;  114 743-749
    Google Scholar
  • 9 Fang X, Hu S, Xu B. et al . 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.  Am J Physiol Heart Circ Physiol. 2006;  290 H55-H63
    Google Scholar
  • 10 Flavell DM, Ireland H, Stephens JW. et al . Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.  Diabetes. 2005;  54 582-586
    Google Scholar
  • 11 Frayling TM, Wiltshire S, Hitman GA. et al . Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11.  Diabetes. 2003;  52 1857-1863
    Google Scholar
  • 12 Froguel P, Zouali H, Vionnet N. et al . Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.  N Engl J Med. 1993;  328 697-702
    Google Scholar
  • 13 Hegele RA, Cao H, Harris SB. et al . The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.  J Clin Endocrinol Metab. 1999;  84 1077-1082
    Google Scholar
  • 14 Hsieh FY, Block DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression.  Stat Med. 1998;  17 1623-1634
    Google Scholar
  • 15 Kleinbaum DG. Logistic regression. 4th ed. New York: Springer 1996;  138-148
  • 16 Liu PY, Li YH, Chao TH. et al . Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.  Atherosclerosis. 2007;  195 199-206
    Google Scholar
  • 17 Liu Y, Zhang Y, Schmelzer K. et al . The antiinflammatory effect of laminar flow: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.  Proc Natl Acad Sci USA. 2005;  102 16747-16752
    Google Scholar
  • 18 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Google Scholar
  • 19 Ng MC, Lee SC, Ko GT. et al . Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity.  Diabetes Care. 2001;  24 663-671
    Google Scholar
  • 20 Node K, Huo Y, Ruan X. et al . Anti-inflammatory properties of cytochrome P450 epoxygenase – derived eicosanoids.  Science. 1999;  285 1276-1279
    Google Scholar
  • 21 Ochi M, Osawa H, Hirota Y. et al . Frequency of the G/G genotype of resistin single nucleotide polymorphism at −420 appears to be increased in younger-onset type 2 diabetes.  Diabetes. 2007;  56 2834-2838
    Google Scholar
  • 22 O’Rahilly S, Spivey RS, Holman RR. et al . Type II diabetes of early onset: a distinct clinical and genetic syndrome?.  BMJ. 1987;  294 923-928
    Google Scholar
  • 23 Owen K, Ayres S, Corbett S. et al . Increased risk of diabetes in first-degree relatives of young-onset type 2 diabetic patients compared with relatives of those diagnosed later.  Diabetes Care. 2002;  25 636-637
    Google Scholar
  • 24 Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes.  J Clin Invest. 2005;  115 1431-1439
    Google Scholar
  • 25 Spiecker M, Darius H, Hankeln T. et al . Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.  Circulation. 2004;  110 2132-2136
    Google Scholar
  • 26 Wang CP, Chung FM, Shin SJ. et al . Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.  Rev Diabet Stud. 2007;  4 77-84
    Google Scholar
  • 27 Wei JN, Sung FC, Lin CC. et al . National surveillance for type 2 diabetes mellitus in Taiwanese children.  JAMA. 2003;  290 1345-1350
    Google Scholar
  • 28 Wolf BA, Turk J, Sherman WR. et al . Intracellular Ca21 mobilization by arachidonic acid. Comparison with myoinositol 1,4,5- trisphosphate in isolated pancreatic islets.  J Biol Chem. 1986;  261 3501-3511
    Google Scholar
  • 29 Wolf BA, Colca JR, Turk J. et al . Regulation of Ca21 homeostasis by islet endoplasmic reticulum and its role in insulin secretion.  Am J Physiol Endocrinol Metab. 1988;  254 E121-E136
    Google Scholar
  • 30 Yamagata K, Furuta H, Oda N. et al . Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1).  Nature. 1996;  384 458-460
    Google Scholar
  • 31 Zeldin DC, Foley J, Boyle JE. et al . Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas.  Endocrinology. 1997;  138 1338-1346
    Google Scholar
  • 32 Zhao X, Dey A, Romanko OP. et al . Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.  Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2005;  288 R188-R196
    Google Scholar

Correspondence

Dr. Y.-J. Lee

Director

Lee's Endocrinologic Clinic

No. 130 Min-Tzu Rd

90000 Pingtung

Taiwan

Phone: +8868-7668901

Fax: +8868-7668902

Email: t3275@ms25.hinet.net